Internal Medicine · Rancho Mirage, CA
NPI
1811993454
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
35400 Bob Hope Dr, Suite 210
Rancho Mirage, CA, 92270
Phone (760) 202-0686
Groups this clinician bills Medicare through
Medicare paid, 2024
$644K
12,104 services
Medicare patients, 2024
712
Average age 72
Drug cost, 2024
$1.5M
8,633 prescriptions
Company payments, 2025
$741
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed F Azam was code 99490 (chronic, principal, and transitional care management), 2,762 times for 509 patients. In total Syed F Azam billed 12,104 services in 86 codes, and Medicare paid $644K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,762 | 509 | $49.77 | $137K |
| 99214 Office E&M - Established | Office | 1,839 | 570 | $91.21 | $168K |
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 802 | 347 | $10.36 | $8,305 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 798 | 236 | $25.53 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 652 | 289 | $12.96 | $8,452 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 583 | 245 | $38.64 | $23K |
| 99497 Care Management/Coordination | Office | 494 | 476 | $77.92 | $38K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 437 | 436 | $19.72 | $8,617 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 431 | 430 | $25.58 | $11K |
| 99215 Office E&M - Established | Office | 410 | 236 | $135.14 | $55K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 382 | 382 | $19.72 | $7,535 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 357 | 357 | $132.77 | $47K |
| 99423 E&M - Miscellaneous | Office | 229 | 121 | $34.63 | $7,931 |
| 99406 Behavioral Health Services | Office | 182 | 136 | $14.87 | $2,707 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 163 | 37 | $36.68 | $5,979 |
By year: 2022 $466K for 6,687 services; 2023 $538K for 8,828 services; 2024 $644K for 12,104 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82570 Clinical Chemistry | 43 | 42 | $5.08 | $218 |
| 82044 Clinical Chemistry | 41 | 40 | $6.11 | $251 |
| 81002 Clinical Chemistry | 29 | 25 | $3.41 | $98.89 |
| 87880 Immunoassay | 11 | 11 | $16.20 | $178 |
Medicare prescription drug claims, 2024
In 2024, the drug Syed F Azam prescribed most often to Medicare patients was Atorvastatin Calcium, with 657 prescriptions and refills. In total Syed F Azam wrote 8,633 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 657 | 1,836 | 204 | $8,113 |
| Amlodipine Besylate Generic | 483 | 1,324 | 147 | $3,501 |
| Fluticasone Propionate Generic | 295 | 436 | 122 | $3,617 |
| Hydrochlorothiazide Generic | 294 | 775 | 88 | $1,403 |
| Losartan Potassium Generic | 288 | 805 | 89 | $3,048 |
| Levothyroxine Sodium Generic | 265 | 753 | 72 | $3,330 |
| Furosemide Generic | 258 | 629 | 93 | $1,247 |
| Metformin Hcl Generic | 254 | 719 | 83 | $1,548 |
| Metoprolol Succinate Generic | 223 | 615 | 62 | $3,375 |
| Rosuvastatin Calcium Generic | 222 | 651 | 79 | $4,505 |
| Lisinopril Generic | 220 | 643 | 79 | $1,882 |
| Mounjaro Tirzepatide | 205 | 219 | 40 | $218K |
| Carvedilol Generic | 193 | 506 | 57 | $1,724 |
| Ozempic Semaglutide | 172 | 273 | 42 | $241K |
| Jardiance Empagliflozin | 171 | 367 | 44 | $197K |
Brand drugs: 1,806 claims; generic drugs: 6,728 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed F Azam $741 ($741 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $144.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 7 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 8 | $135 |
| Amgen Inc. AMGN | 5 | $107 |
| GlaxoSmithKline, LLC. GSK | 3 | $75.63 |
| Abbvie Inc. ABBV | 3 | $66.69 |
| Pfizer Inc. PFE | 2 | $50.53 |
| Lilly USA, LLC LLY | 2 | $47.94 |
| Viatris Specialty LLC | 2 | $46.82 |
| Astellas Pharma US Inc 4503.T | 1 | $27.3 |
| Exact Sciences Corporation EXAS | 1 | $24.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.